논문 상세보기

Effects of Changes in Glycosylation Sites on Secretion of Recombinant Human Erythropoietin in Cultured CHO Cells

  • 언어ENG
  • URLhttps://db.koreascholar.com/Article/Detail/61974
구독 기관 인증 시 무료 이용이 가능합니다. 4,000원
한국동물번식학회 (The Korean Society of Animal Reproduction)
초록

The effects of additions/deletions in glycosylated residues of recombinant human EPO (rhEPO) produced in CHO-K1 on their secretion were examined. hEPO cDNA was amplified from human liver mRNA and cloned into the pCR2.1 TOPO. Using overlapping-extension site-directed mutagenesis method, glycosylation sites at 24th, 38th, 83rd, and 126th were respectively or accumulatively removed by substituting its asparagine (or serine) with glutamine. To add novel glycosylation sites, 69 and 105th leucine was mutated to asparagine. Mutant and wild type rhEPO constructs were cloned into the pcDNA3 expression vector with CMV promoter and transfected into CHO cell line, CHO-K1, to produce mutant rhEPO mutant rhEPO proteins. Enzyme-linked immunosorbant assay (ELISA) and Western analysis with monoclonal anti-EPO antibody were performed using supernatants of the cultures showing transient and stable expressions respectively. Addition of novel glycosylation reduced rhEPO secretion dramatically while deletion mutants had little effect except some double deletion mutants (△24/83 and △38/83) and triple mutant (△24/38/83). This fact suggests that not single but combination of changes in glycosyl groups affect secretion of rhEPO in cell culture, possibly via changes in their conformations.

저자
  • Lee, H. G(Animal Biotechnology Division, NLRI, RDA)
  • P. Y. Lee(Animal Biotechnology Division, NLRI, RDA)
  • Y. K. Lee(Animal Biotechnology Division, NLRI, RDA)
  • S. J. Kim(Animal Biotechnology Division, NLRI, RDA)
  • H. K. Chung(Animal Biotechnology Division, NLRI, RDA)
  • M. K. Seo(Animal Biotechnology Division, NLRI, RDA)
  • J. K. Park(Animal Biotechnology Division, NLRI, RDA)
  • K. S. Min(Graduate School of Bio & Information Technology, Hankyong National University)
  • W. K. Chang(Animal Biotechnology Division, NLRI, RDA)